The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABEONA THERAPEUTICS INC | COM | 00289Y107 | 3,971 | 3,892,921 | SH | DFND | 1,2 | 3,892,921 | 0 | 0 | |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 79,264 | 1,921,563 | SH | DFND | 1,2 | 1,921,563 | 0 | 0 | |
ALLOGENE THERAPEUTICS INC | COM | 019770106 | 12,400 | 328,817 | SH | DFND | 1,2 | 328,817 | 0 | 0 | |
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 74,558 | 996,898 | SH | DFND | 1,2 | 996,898 | 0 | 0 | |
AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 36,609 | 2,485,327 | SH | DFND | 1,2 | 2,485,327 | 0 | 0 | |
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 28,279 | 435,000 | SH | DFND | 1,2 | 435,000 | 0 | 0 | |
CALITHERA BIOSCIENCES INC | COM | 13089P101 | 10,069 | 2,918,581 | SH | DFND | 1,2 | 2,918,581 | 0 | 0 | |
CHEMOCENTRYX INC | COM | 16383L106 | 13,877 | 253,230 | SH | DFND | 1,2 | 253,230 | 0 | 0 | |
CONSTELLATION PHARMCETICLS I | COM | 210373106 | 57,983 | 2,861,924 | SH | DFND | 1,2 | 2,861,924 | 0 | 0 | |
CYTOKINETICS INC | COM NEW | 23282W605 | 5,477 | 253,000 | SH | Put | DFND | 1,2 | 253,000 | 0 | 0 |
CYTOKINETICS INC | COM NEW | 23282W605 | 55,197 | 2,549,525 | SH | DFND | 1,2 | 2,549,525 | 0 | 0 | |
GERON CORP | COM | 374163103 | 16,853 | 9,685,528 | SH | DFND | 1,2 | 9,685,528 | 0 | 0 | |
GLAUKOS CORP | COM | 377322102 | 22,091 | 446,097 | SH | DFND | 1,2 | 446,097 | 0 | 0 | |
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 36,154 | 655,676 | SH | DFND | 1,2 | 655,676 | 0 | 0 | |
GW PHARMACEUTICALS PLC | ADS | 36197T103 | 50,645 | 520,232 | SH | DFND | 1,2 | 520,232 | 0 | 0 | |
INTERSECT ENT INC | COM | 46071F103 | 12,199 | 747,926 | SH | DFND | 1,2 | 747,926 | 0 | 0 | |
INVENTIVA SA | ADS | 46124U107 | 11,813 | 999,422 | SH | DFND | 1,2 | 999,422 | 0 | 0 | |
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 127,618 | 3,876,600 | SH | DFND | 1,2 | 3,876,600 | 0 | 0 | |
KADMON HLDGS INC | COM | 48283N106 | 9,800 | 2,500,000 | SH | DFND | 1,2 | 2,500,000 | 0 | 0 | |
LANTHEUS HLDGS INC | COM | 516544103 | 7,535 | 594,750 | SH | DFND | 1,2 | 594,750 | 0 | 0 | |
LIQUIDIA TECHNOLOGIES INC | COM | 53635D202 | 5,853 | 1,189,607 | SH | DFND | 1,2 | 1,189,607 | 0 | 0 | |
MACROGENICS INC | COM | 556099109 | 38,042 | 1,510,215 | SH | DFND | 1,2 | 1,510,215 | 0 | 0 | |
MILLENDO THERAPEUTICS INC | COM | 60040X103 | 1,920 | 1,177,900 | SH | DFND | 1,2 | 1,177,900 | 0 | 0 | |
OYSTER PT PHARMA INC | COM | 69242L106 | 1,480 | 70,121 | SH | DFND | 1,2 | 70,121 | 0 | 0 | |
PROTHENA CORP PLC | SHS | G72800108 | 15,469 | 1,548,479 | SH | DFND | 1,2 | 1,548,479 | 0 | 0 | |
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 11,120 | 1,102,073 | SH | DFND | 1,2 | 1,102,073 | 0 | 0 | |
SAGE THERAPEUTICS INC | COM | 78667J108 | 120,204 | 1,966,688 | SH | DFND | 1,2 | 1,966,688 | 0 | 0 | |
SANGAMO THERAPEUTICS INC | COM | 800677106 | 15,023 | 1,589,724 | SH | DFND | 1,2 | 1,589,724 | 0 | 0 | |
TG THERAPEUTICS INC | COM | 88322Q108 | 42,816 | 1,600,000 | SH | DFND | 1,2 | 1,600,000 | 0 | 0 | |
TRANSLATE BIO INC | COM | 89374L104 | 12,839 | 943,339 | SH | DFND | 1,2 | 943,339 | 0 | 0 | |
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 64,718 | 640,773 | SH | DFND | 1,2 | 640,773 | 0 | 0 | |
VERICEL CORP | COM | 92346J108 | 27,439 | 1,480,787 | SH | DFND | 1,2 | 1,480,787 | 0 | 0 | |
VIEWRAY INC | COM | 92672L107 | 9,295 | 2,655,763 | SH | DFND | 1,2 | 2,655,763 | 0 | 0 | |
ZYMEWORKS INC | COM | 98985W102 | 73,033 | 1,567,900 | SH | DFND | 1,2 | 1,567,900 | 0 | 0 |